Effective October 6, 2014, Hydrocodone Combination Products (HCPs) will be schedule II substances under the Controlled Substances Act (CSA). For prescribers, the change primarily means that they may not authorize refills for any HCP prescriptions. However, they may issue multiple prescriptions authorizing a patient to receive a total of up to a 90-day supply of HCPs (if state law permits). DEA is allowing HCP prescriptions issued before October 6, 2014 that authorize refills to be refilled until April 8, 2015.